Multidimensional analysis of the pathological mechanisms of infantile hemangioma: metabolic reprogramming, immune remodeling, and programmed cell death
- 1Shengjing Hospital of China Medical University
- 2School of Clinical Medicine, Hainan Medical University
- 3The First Affiliated Hospital, Hainan Medical University
Abstract
Infantile hemangioma (IH) is a common benign vascular tumor of infancy. Its self-limiting course, which progresses from proliferation to involution, involves aberrant angiogenesis, altered cell fate, and remodeling of the lesional microenvironment. Hypoxia/HIF-VEGF, PI3K/AKT, MAPK/ERK, and Notch signaling pathways contribute to vascular formation and cellular differentiation. During the proliferative phase, hemangioma endothelial cells (HemECs) undergo metabolic reprogramming characterized by enhanced glycolysis and altered amino acid metabolism, including pathways involving glutamine, arginine, glycine, and serine. Macrophages, mast cells, T cells, and their associated cytokines also shape a proangiogenic immune microenvironment. During the involuting phase, the transition of hemangioma stem cells (HemSCs) toward an adipogenic fate, together with changes in lesional cell composition, contributes to fibrofatty tissue remodeling. At the same time, the immune microenvironment undergoes stage-dependent remodeling, and processes related to programmed cell death, including apoptosis, pyroptosis, necroptosis, ferroptosis, and autophagy, change accordingly. However, the strength of evidence supporting these processes in IH varies. Current studies have identified specific links among metabolism, immunity, and cell death, but they have not established a fixed, sequential causal cascade; PANoptosis remains an unverified mechanistic hypothesis in IH. Although propranolol is the first-line treatment, variable treatment responses, rebound growth after treatment withdrawal, and refractory lesions remain clinical challenges. Focusing on the transition from proliferation to involution, this review integrates current evidence and potential mechanistic connections to inform research on spontaneous involution and the development of interventions tailored to specific disease stages and cell types.
Related
- Protein S-nitrosylation in the heart: Mechanisms, physiological roles, and pathological remodeling
- Postpartum hemorrhagic vertebral hemangioma with pathological vertebral fracture: A case report highlighting spinal instability as a potential mechanical cofactor.
- Mechanisms of infantile hemangioma involution (Review).
- The Shared Pathological Niche in Pulmonary Fibrosis: From Aberrant Epithelial Repair to ECM Remodeling
- Anthracycline Cardiotoxicity as Multicellular Network Failure: Cardiac Niche Reprogramming and Pathological Cell–Cell Communication
BibTeX
@article{liang2026multidimensional,
title = {{Multidimensional analysis of the pathological mechanisms of infantile hemangioma: metabolic reprogramming, immune remodeling, and programmed cell death}},
author = {Haoyi Liang and Haizhou Pan and Yangjinyi An and Yongjia Chen and Wenbo Li and Ziming Wei and Chong Liu and Houfan Zhu and Haidi Hu},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.1971229},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1971229/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Multidimensional analysis of the pathological mechanisms of infantile hemangioma: metabolic reprogramming, immune remodeling, and programmed cell death
AU - Haoyi Liang
AU - Haizhou Pan
AU - Yangjinyi An
AU - Yongjia Chen
AU - Wenbo Li
AU - Ziming Wei
AU - Chong Liu
AU - Houfan Zhu
AU - Haidi Hu
PY - 2026
DA - 2026/11/04
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1971229
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1971229/full
AB - Infantile hemangioma (IH) is a common benign vascular tumor of infancy. Its self-limiting course, which progresses from proliferation to involution, involves aberrant angiogenesis, altered cell fate, and remodeling of the lesional microenvironment. Hypoxia/HIF-VEGF, PI3K/AKT, MAPK/ERK, and Notch signaling pathways contribute to vascular formation and cellular differentiation. During the proliferative phase, hemangioma endothelial cells (HemECs) undergo metabolic reprogramming characterized by enhanced glycolysis and altered amino acid metabolism, including pathways involving glutamine, arginine, glycine, and serine. Macrophages, mast cells, T cells, and their associated cytokines also shape a proangiogenic immune microenvironment. During the involuting phase, the transition of hemangioma stem cells (HemSCs) toward an adipogenic fate, together with changes in lesional cell composition, contributes to fibrofatty tissue remodeling. At the same time, the immune microenvironment undergoes stage-dependent remodeling, and processes related to programmed cell death, including apoptosis, pyroptosis, necroptosis, ferroptosis, and autophagy, change accordingly. However, the strength of evidence supporting these processes in IH varies. Current studies have identified specific links among metabolism, immunity, and cell death, but they have not established a fixed, sequential causal cascade; PANoptosis remains an unverified mechanistic hypothesis in IH. Although propranolol is the first-line treatment, variable treatment responses, rebound growth after treatment withdrawal, and refractory lesions remain clinical challenges. Focusing on the transition from proliferation to involution, this review integrates current evidence and potential mechanistic connections to inform research on spontaneous involution and the development of interventions tailored to specific disease stages and cell types.
SN - 1663-9812
ER -